mrmarket.ai
Stock Overview

Teva Pharma Industries Ltd ADR (TEVA)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Teva Pharma Industries Ltd ADR is a Healthcare company with a market capitalization of $41.60B and a trailing P/E ratio of 59.5.

Market Cap
$41.60B
P/E (TTM)
59.5
Forward P/E
17.2
Price/Sales
2.4
Price/Book
5.4
EV/EBITDA
20.9
Beta
0.88
EPS (TTM)
$0.60
Profit Margin
9.0%
ROE
9.7%
Short % of Float
3.0%
Days to Cover
6.5
52W High
$36.74
52W Low
$17.54

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025

Revenue
$17.26B
Gross Profit
$8.94B
Operating Income
$2.16B
Net Income
$1.41B
Free Cash Flow
$1.15B
Total Debt
$16.81B
Cash & Equivalents
$3.56B
Shareholder Equity
$7.91B

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026April 29, 2026$0.53$0.46+15.2%
Q4 2025January 28, 2026$0.96$0.64+50.0%
Q3 2025November 5, 2025$0.75$0.66+13.6%
Q2 2025July 30, 2025$0.66$0.62+6.5%
Q1 2025May 7, 2025$0.52$0.46+13.0%
Q4 2024January 29, 2025$0.71$0.70+1.4%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202632,741,0112.78%6.5+2.2%
June 30, 202632,029,6572.72%5.1-4.0%
June 15, 202633,346,8912.83%5.4-1.5%
May 29, 202633,869,0082.87%6.0+27.1%
May 15, 202626,651,4582.26%4.0-14.4%
April 30, 202631,140,4572.64%4.0+4.7%
April 15, 202629,736,3982.54%7.1+10.0%
March 31, 202627,042,7482.31%3.8-28.1%

Other Drug Manufacturers - Specialty & Generic Stocks

TAK
Takeda Pharmaceutical Co Ltd ADR
$55.20B
HLN
Haleon plc
$43.55B
ZTS
Zoetis Inc
$30.42B
UTHR
United Therapeutics Corporation
$21.87B
VTRS
Viatris Inc
$18.59B
NBIX
Neurocrine Biosciences Inc
$15.19B
ELAN
Elanco Animal Health
$11.15B
RDY
Dr. Reddy’s Laboratories Ltd ADR
$10.42B
TEVA vs TAKTEVA vs HLNTEVA vs ZTS

Frequently Asked Questions

What is Teva Pharma Industries Ltd ADR's market cap?

As of August 13, 2026, Teva Pharma Industries Ltd ADR (TEVA) has a market capitalization of $41.60B.

What is Teva Pharma Industries Ltd ADR's P/E ratio?

Teva Pharma Industries Ltd ADR trades at a trailing price-to-earnings (P/E) ratio of 59.5. Its forward P/E is 17.2.

Does Teva Pharma Industries Ltd ADR pay a dividend?

Teva Pharma Industries Ltd ADR does not currently pay a dividend.

What sector is TEVA in?

Teva Pharma Industries Ltd ADR is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

What is Teva Pharma Industries Ltd ADR's short interest?

As of the July 15, 2026 FINRA settlement, 32,741,011 TEVA shares were sold short, or 2.78% of shares outstanding. Days to cover: 6.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Teva Pharma Industries Ltd ADR's revenue?

In its latest reported fiscal year (ending December 31, 2025), Teva Pharma Industries Ltd ADR reported revenue of $17.26B and net income of $1.41B.

Ask your own questions about TEVA

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.